E-Biotorium Under Government Attention Over Biomagnetic Mattress Health Claims.

E-Biotorium Investigation India: Biomagnetic Mattress Claims and Direct Selling Model Face Regulatory Scrutiny

Indian authorities are scrutinising E-Biotorium Network Pvt Ltd over biomagnetic mattress health claims, direct selling practices, and leadership disclosures linked to alleged fraudster and alleged rape accused Sagar Ramakant Joshi, amid concerns about misleading medical advertising, possible unregulated deposit schemes, consumer protection violations, and regulatory gaps across India’s wellness industry.

The E-Biotorium investigation in India has intensified as regulators examine biomagnetic mattress health claims, sales practices, and corporate disclosures, raising wider concerns about consumer protection, public health safety, and financial compliance frameworks.

E-Biotorium Network Pvt Ltd, operating across India markets biomagnetic mattresses and wellness products through a direct selling network, attracting attention from consumer authorities and law enforcement agencies.

Officials are reviewing whether the company’s promotional representations comply with Indian consumer protection laws, advertising regulations, and financial rules governing wellness products sold through network based business models.

The case is significant as India’s fast growing alternative wellness market increasingly targets vulnerable consumers seeking affordable solutions for chronic and life threatening medical conditions.

Health Claims Versus Medical Evidence in Biomagnetic Products

E-Biotorium promotes biomagnetic mattresses and accessories as offering benefits for serious illnesses including cancer, diabetes, and cardiovascular diseases, according to promotional material examined during regulatory reviews.

Medical professionals contacted for this investigation state that static magnet therapy lacks peer reviewed scientific evidence supporting claims of curing or reversing serious or terminal diseases.

Health policy specialists warn that such marketing can result in treatment displacement, where patients delay or discontinue evidence based medical care in favour of unverified alternatives.

Such delays can worsen health outcomes, increase mortality risks, and undermine trust in regulated healthcare systems designed to deliver proven treatments.

Under the Drugs and Magic Remedies Objectionable Advertisements Act, advertisements claiming cures for specified diseases without scientific validation are explicitly prohibited.

Regulators are examining whether E-Biotorium’s marketing content breached these provisions by implying therapeutic effectiveness unsupported by recognised medical research.

Consumer Protection Authority Review and Compliance Assessment

Sources confirm that the Central Consumer Protection Authority previously reviewed E-Biotorium over issues related to misleading advertising and consumer rights compliance.

Regulatory records indicate that the company has faced repeated scrutiny for its promotional practices and remains under review for compliance with corrective directions issued earlier.

Officials emphasise that continued non compliance may invite additional administrative action, penalties, or restrictions under consumer protection statutes.

Consumer law experts note that repeated enforcement actions often signal systemic compliance weaknesses rather than isolated lapses.

They stress that consistent oversight is critical to prevent misleading health claims from reappearing under new promotional formats.

Direct Selling Model and Financial Compliance Concerns

Separately, authorities are examining whether the company’s compensation structure places disproportionate emphasis on recruitment rather than genuine product sales value.

In January 2023, Bengaluru police detained individuals identified as associates linked to the company during investigations into unregulated deposit and money circulation schemes.

Police records and contemporaneous media reports indicate that the matter was reviewed under laws governing illegal deposit collection and pyramid style business activities.

Regulators are assessing whether the business model aligns with the Banning of Unregulated Deposit Schemes Act, 2019.

The Act prohibits income structures primarily driven by participant recruitment rather than legitimate product or service value.

Legal analysts say such probes reflect growing regulatory focus on hybrid wellness and investment schemes operating within legal grey areas.

Leadership Background and Disclosure Obligations Under Review

Attention has also focused on the background and statutory disclosures of individuals associated with the company’s leadership.

Publicly accessible court records show that a rape case was registered in 2015 at Kasturba Marg Police Station, Mumbai, against Sagar Ramakant Joshi, a director and promoter linked to E-Biotorium.

Court listings further indicate a separate rape related case registered at Naigaon Police Station, now committed to the Sessions Court at Vasai, Maharashtra, following a charge sheet filed in 2025.

Legal experts clarify that while every accused person is entitled to the presumption of innocence, disclosure of pending criminal proceedings is a material requirement under corporate governance frameworks.

Authorities are examining whether statutory declarations submitted to regulatory bodies accurately reflected these disclosures.

Also Read: ₹500 Crore Thane Investment Scam Shocks Thousands.

Related Article: Rape Accused Misuse Fake Doctor Titles in India.

Use of Doctor Title and Consumer Perception Risks

Investigators have also raised questions regarding the public use of the title Doctor by Sagar Ramakant Joshi in marketing material for E-Biotorium products.

Joshi has attributed the title to an honorary doctorate allegedly awarded by an institution described as an American university.

Education experts note that honorary doctorates do not confer medical qualifications or authorise individuals to present themselves as medical practitioners.

Preliminary reviews indicate that the institution cited does not appear in databases of United States Department of Education recognised or regionally accredited universities.

Consumer advocates warn that such titles may mislead vulnerable consumers into assuming medical endorsement or clinical expertise.

This risk is amplified when wellness products are promoted as permanent solutions to serious health conditions.

Why the E-Biotorium Case Has Wider Policy Implications

India’s expanding wellness and alternative health market has outpaced enforcement capacity, allowing questionable claims to spread through seminars, messaging platforms, and network based sales channels.

Consumer rights groups argue the E-Biotorium case highlights the need for stronger oversight of health related advertising and clearer disclosure norms for direct selling entities.

They also call for closer coordination between health regulators, consumer protection authorities, and financial crime agencies.

Sprouts News notes that outcomes of this investigation could influence future regulatory reforms governing wellness marketing and network based sales structures.

Authorities advise citizens to verify medical claims with licensed doctors and report suspected violations through the National Consumer Helpline or relevant regulatory portals.

Unmesh Gujarathi, an investigative journalist, was the first to expose the alleged scam, bringing critical issues related to the company’s practices and leadership into the public domain.

Disclaimer: This report is based on publicly available court records, regulatory communications, and expert opinions. All individuals mentioned are presumed innocent until proven otherwise by a court of law. Responses from the company or individuals named will be published if received.